ClinicalTrials.Veeva

Menu

Moxibustion Plus Cupping in Convalescent Patients With COVID-19

G

Guang'anmen Hospital of China Academy of Chinese Medical Sciences

Status

Unknown

Conditions

COVID-19
Convalescence

Treatments

Other: Moxibustion plus Cupping

Study type

Interventional

Funder types

Other

Identifiers

NCT04374084
2020YFC0845000

Details and patient eligibility

About

This trial is designed to evaluate the efficacy and safety of moxibustion plus cupping in the convalescence of COVID-19.

Full description

Moxibustion plus cupping may be effective and safe for convalescent patients with COVID-19, but evidence is limited. The randomized clinical trial may help to provide evidence-based factors for improving the patients' symptoms in the convalescence of COVID-19.

Enrollment

60 estimated patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Clinical diagnosis of the convalescence of COVID-19 (defined by the Chinese Guideline for COVID-19 in 2020 Trial Version 7).
  2. 18-70 years old;
  3. chest tightness/fatigue/shortness of breath/cough, with at least 2 of the above symptoms and the average VAS score (last 48 hours) ≥ 40 points;
  4. Volunteers with informed consent;

Exclusion criteria

  1. Surgery in the lung that affects lung function;
  2. Rely on mechanical ventilation to maintain lung function;
  3. Chronic lung diseases affecting lung function;
  4. Diseases affecting heart function;
  5. Severe basic diseases;
  6. Resting heart rate > 120/min, systolic blood pressure > 180mmHg, diastolic blood pressure > 100mmHg;
  7. Unstable angina or myocardial infarction in the past 1 month;
  8. Severe obesity (BMI>30kg/m2);
  9. Allergic constitution;
  10. Pregnant or lactating women;
  11. Disabled patients;
  12. Mentally ill Patients;
  13. Participating in other clinical trials;
  14. Poor compliance or other complicate conditions according to the researchers.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

60 participants in 2 patient groups

Moxibustion plus Cupping
Experimental group
Description:
Moxibustion plus cupping and basic therapy (rehabilitation direction and basic breathing exercise) once a day for 4 weeks (28 sessions).The moxibustion plus cupping treatments were divided into 2 alternating formulas: A: Monday, Wednesday, Friday and Sunday: moxibustion on bilateral Fengmen (BL12), Feishu (BL13) and Pishu(BL20) B: Tuesday, Thursday and Saturday: moxibustion on Zhongwan (RN12), Qihai (RN6), bilateral Tianshu(ST25) and Zusanli(ST36) + cupping on bilateral Feishu(BL13) Geshu(BL17) Pishu(BL20) The 2 formulas were used alternatively every other day, 7 times per week, for 4 weeks. Moxibustion acupoint addition: profuse sweating added Fuliu (KI7), insomnia added Shenmen(HT7) anxiety or depression added Neiguan (PC6).
Treatment:
Other: Moxibustion plus Cupping
Basic therapy
No Intervention group
Description:
Basic therapy: rehabilitation direction and basic breathing exercise.

Trial contacts and locations

1

Loading...

Central trial contact

Jiani Wu

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems